Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance.
- NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_assertion description "[VPY is a novel PepT1 substrate that can inhibit the production of pro-inflammatory mediators in vitro in intestinal epithelial and immune cells, and reduce the severity of colitis in mice by down-regulating the expression of pro-inflammatory cytokines in the colon, suggesting that VPY may be promising for the treatment of IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance.
- NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_assertion evidence source_evidence_literature NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance.
- NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_assertion SIO_000772 22842481 NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance.
- NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_assertion wasDerivedFrom befree-2016 NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance.
- NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_assertion wasGeneratedBy ECO_0000203 NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance.
- befree-2016 importedOn "2016-02-19" NP1001048.RAabB0ab7EruaCWLBodPP_DNz8qsg3-rEJa5laszpNWoY130_provenance.